CRL
$337.52+7.83%
as of close, Nov 6, 2026
☾ AH $337.52 +7.83%
Charles River LaboratoriesStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.02% of SPYRussell 3000 · 0.02% of IWVRussell 1000 · 0.02% of IWBUS Stock Market · 0.02% of VTI
Head-to-head:Compare with RVTY or any ticker →
Charles River Laboratories monthly returns
Charles River Laboratories has averaged 1.35% a month with dividends reinvested, and risen in 57% of months, through November 6, 2026. The table lists the most recent months; the chart, the last 5 years.
Average month
+1.3%
317 months
Best month
+36.1%
Jul 2000
Worst month
-36.4%
Nov 2008
Positive months
57%
of all months
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -6.1% | |
| Oct 2026 | +21.8% | |
| Sep 2026 | +2.3% | |
| Aug 2026 | +24.0% | |
| Jul 2026 | +4.0% | |
| Jun 2026 | +23.7% | |
| May 2026 | +8.2% | |
| Apr 2026 | -3.2% | |
| Mar 2026 | -3.4% | |
| Feb 2026 | -15.2% | |
| Jan 2026 | +5.5% | |
| Dec 2025 | +12.0% | |
| Nov 2025 | -1.1% | |
| Oct 2025 | +15.1% | |
| Sep 2025 | -4.2% | |
| Aug 2025 | -3.7% | |
| Jul 2025 | +11.8% | |
| Jun 2025 | +11.9% | |
| May 2025 | +14.3% | |
| Apr 2025 | -21.2% | |
| Mar 2025 | -8.9% | |
| Feb 2025 | +0.3% | |
| Jan 2025 | -10.7% | |
| Dec 2024 | -7.3% | |
| Nov 2024 | +11.5% | |
| Oct 2024 | -9.3% | |
| Sep 2024 | -0.4% | |
| Aug 2024 | -19.0% | |
| Jul 2024 | +18.2% | |
| Jun 2024 | -0.9% | |
| May 2024 | -9.0% | |
| Apr 2024 | -15.5% | |
| Mar 2024 | +6.6% | |
| Feb 2024 | +17.5% | |
| Jan 2024 | -8.5% | |
| Dec 2023 | +20.0% | |
| Nov 2023 | +17.1% | |
| Oct 2023 | -14.1% | |
| Sep 2023 | -5.2% | |
| Aug 2023 | -1.3% | |
| Jul 2023 | -0.3% | |
| Jun 2023 | +8.7% | |
| May 2023 | +1.7% | |
| Apr 2023 | -5.8% | |
| Mar 2023 | -8.0% | |
| Feb 2023 | -9.8% | |
| Jan 2023 | +11.6% | |
| Dec 2022 | -4.7% | |
| Nov 2022 | +7.7% | |
| Oct 2022 | +7.9% | |
| Sep 2022 | -4.1% | |
| Aug 2022 | -18.1% | |
| Jul 2022 | +17.1% | |
| Jun 2022 | -8.6% | |
| May 2022 | -3.1% | |
| Apr 2022 | -15.0% | |
| Mar 2022 | -2.5% | |
| Feb 2022 | -11.7% | |
| Jan 2022 | -12.5% | |
| Dec 2021 | +3.0% | |
| Nov 2021 | -18.5% | |
| Oct 2021 | +8.7% | |
| Sep 2021 | -7.0% | |
| Aug 2021 | +9.1% | |
| Jul 2021 | +10.0% | |
| Jun 2021 | +9.4% | |
| May 2021 | +1.7% | |
| Apr 2021 | +14.7% | |
| Mar 2021 | +1.3% | |
| Feb 2021 | +10.5% | |
| Jan 2021 | +3.7% | |
| Dec 2020 | +6.5% | |
| Nov 2020 | +3.0% | |
| Oct 2020 | +0.6% | |
| Sep 2020 | +3.4% | |
| Aug 2020 | +10.0% | |
| Jul 2020 | +14.1% | |
| Jun 2020 | -3.0% | |
| May 2020 | +24.2% | |
| Apr 2020 | +14.6% | |
| Mar 2020 | -18.9% | |
| Feb 2020 | +0.6% | |
| Jan 2020 | +1.2% | |
| Dec 2019 | +5.2% | |
| Nov 2019 | +11.7% | |
| Oct 2019 | -1.8% | |
| Sep 2019 | +0.9% | |
| Aug 2019 | -2.5% | |
| Jul 2019 | -5.2% | |
| Jun 2019 | +13.1% | |
| May 2019 | -10.7% | |
| Apr 2019 | -3.3% | |
| Mar 2019 | +2.2% | |
| Feb 2019 | +15.4% | |
| Jan 2019 | +8.8% | |
| Dec 2018 | -16.1% | |
| Nov 2018 | +10.7% | |
| Oct 2018 | -9.5% | |
| Sep 2018 | +8.9% | |
| Aug 2018 | -0.6% | |
| Jul 2018 | +10.7% | |
| Jun 2018 | +4.4% | |
| May 2018 | +3.2% | |
| Apr 2018 | -2.4% | |
| Mar 2018 | +0.1% | |
| Feb 2018 | +1.1% | |
| Jan 2018 | -3.7% | |
| Dec 2017 | +5.0% | |
| Nov 2017 | -10.4% | |
| Oct 2017 | +7.7% | |
| Sep 2017 | -0.7% | |
| Aug 2017 | +10.8% | |
| Jul 2017 | -2.9% | |
| Jun 2017 | +9.9% | |
| May 2017 | +2.6% | |
| Apr 2017 | -0.3% | |
| Mar 2017 | +3.4% | |
| Feb 2017 | +7.6% | |
| Jan 2017 | +6.1% | |
| Dec 2016 | +7.2% |
Monthly total return (since Dec 2021)#
-20%-10%0%10%20%
Dec 2021+3.0%
Jan 2022-12%2022
Feb 2022-12%
Mar 2022-2.5%
Apr 2022-15%
May 2022-3.1%
Jun 2022-8.6%
Jul 2022+17%
Aug 2022-18%
Sep 2022-4.1%
Oct 2022+7.9%
Nov 2022+7.7%
Dec 2022-4.7%
Jan 2023+12%2023
Feb 2023-9.8%
Mar 2023-8.0%
Apr 2023-5.8%
May 2023+1.7%
Jun 2023+8.7%
Jul 2023-0.34%
Aug 2023-1.3%
Sep 2023-5.2%
Oct 2023-14%
Nov 2023+17%
Dec 2023+20%
Jan 2024-8.5%2024
Feb 2024+18%
Mar 2024+6.6%
Apr 2024-15%
May 2024-9.0%
Jun 2024-0.89%
Jul 2024+18%
Aug 2024-19%
Sep 2024-0.39%
Oct 2024-9.3%
Nov 2024+11%
Dec 2024-7.3%
Jan 2025-11%2025
Feb 2025+0.33%
Mar 2025-8.9%
Apr 2025-21%
May 2025+14%
Jun 2025+12%
Jul 2025+12%
Aug 2025-3.7%
Sep 2025-4.2%
Oct 2025+15%
Nov 2025-1.1%
Dec 2025+12%
Jan 2026+5.5%2026
Feb 2026-15%
Mar 2026-3.4%
Apr 2026-3.2%
May 2026+8.2%
Jun 2026+24%
Jul 2026+4.0%
Aug 2026+24%
Sep 2026+2.3%
Oct 2026+22%
Nov 2026-6.1%
Charles River Laboratories returns by calendar month#
Every month of every year since 2000, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -6.09% — 20th of 27 Novembers since 2000 at the last close; the average November returned -0.6%.
| Month | −40%0+40% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +2.0% | +3.9% | 65% | +23.6% 2012 | -22.6% 2003 | |
| Feb | +0.9% | +0.9% | 62% | +17.5% 2024 | -15.2% 2026 | |
| Mar | +0.3% | +1.8% | 73% | +9.7% 2009 | -18.9% 2020 | |
| Apr | -2.1% | -1.7% | 38% | +14.7% 2021 | -21.2% 2025 | |
| May | +4.6% | +2.2% | 65% | +27.8% 2001 | -15.3% 2006 | |
| Jun | +2.7% | +0.8% | 54% | +23.7% 2026 | -8.6% 2022 | |
| Jul | +5.1% | +4.0% | 63% | +36.1% 2000 | -10.9% 2001 | |
| Aug | +0.5% | -0.6% | 48% | +24.0% 2026 | -19.0% 2024 | |
| Sep | +0.2% | +0.2% | 52% | +23.9% 2000 | -15.4% 2008 | |
| Oct | -0.8% | +0.3% | 52% | +21.8% 2026 | -35.5% 2008 | |
| Nov | -0.6% | +0.3% | 50% | +17.4% 2015 | -36.4% 2008 | |
| Dec | +3.7% | +4.2% | 69% | +28.1% 2000 | -16.1% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from CRL's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Charles River Laboratories's average monthly return?
- Charles River Laboratories has averaged about 1.35% per month (dividends reinvested), positive in roughly 57% of months. The best month was Jul 2000 (+36.1%) and the worst was Nov 2008 (-36.4%).
More on Charles River Laboratories
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with RVTY or any ticker →